Imatinib mesylate enhances therapeutic effects of gemcitabine in human malignant mesothelioma xenografts
Pietro Bertino, Federica Piccardi, Camillo Porta, Roberto Favoni, Michele Cilli, Luciano Mutti, Giovanni Gaudino
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Imatinib mesylate enhances therapeutic effects of gemcitabine in human malignant mesothelioma xenografts'. Together they form a unique fingerprint.